Circulating adropin and vascular endothelial growth factor receptor-2 levels in age-related macular degeneration and T2DM patients-A cross-sectional study.

J Family Med Prim Care · 2020 · PMC7652138 · PMID 33209815

Europe PMC DOI

hedged sentences

0.0500

closest p · 1.0× alpha

0.0500

boldest claim

The sentences

at the threshold of significanceP = 0.05actually significant

Adropin is at the threshold of significance ( P = 0.05), exhibiting the expected increase among the cases, though not significantly.

also in 82 other papers

an interesting trendno p-value reported

An interesting trend has been observed in our study, and it was the apparent blood glucose-lowering trend of adropin among the cases.

also in 1,783 other papers

an increasing trendno p-value reported

But adropin did exhibit an increasing trend in the AMD group.

also in 63,971 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.